FIELD: medicine, oncology, amino acids.
SUBSTANCE: invention relates, in particular, to the development of an antitumor preparation based on natural substances. Invention relates to an amino acid preparation comprising at least one modified essential amino acid obtained by treatment of amino acid by ultraviolet radiation (UV) at wavelength 250-350 nm for 12-80 h at temperature 15-30oC or with ozone at temperature 15-25oC. The modified amino acid has no toxicity for health cells. Also, invention relates to a method for preparing such preparation. Invention provides the development of an antitumor preparation based on modified amino acids and expanded assortment of antitumor preparations being without cytotoxicity for normal cells.
EFFECT: valuable medicinal antitumor properties of preparation.
8 cl, 4 tbl, 2 dwg, 4 ex
Title | Year | Author | Number |
---|---|---|---|
ANTITUMOR PREPARATION AND METHOD FOR ITS OBTAINING | 2001 |
|
RU2182480C1 |
PREPARATION AND METHOD FOR REMOVING SIDE EFFECT OF ANTITUMOR PRODUCTS | 2001 |
|
RU2197957C1 |
PREPARATION AND METHOD FOR PRODUCING THE PREPARATION FOR TREATING ALCOHOLISM AND DRUG ADDICTION | 2003 |
|
RU2252756C1 |
PEPTIDE WITH ANTITUMOUR ACTIVITY | 2021 |
|
RU2771492C1 |
GLYCOPROTEIN TCF-II AND PHARMACEUTICAL COMPOSITION CONTAINING EFFECTIVE AMOUNT OF GLYCOPROTEIN TCF-II | 1991 |
|
RU2097432C1 |
MONOMOLECULAR CHIMERIC T-CELL RECEPTOR TO CANCER ANTIGEN CA125 | 2018 |
|
RU2747095C2 |
DECAPEPTIDE SHOWING ANTITUMOR ACTIVITY | 1993 |
|
RU2084458C1 |
ANTITUMOR PEPTIDE PREPARATION BASED ON ALPHA-FETOPROTEIN FRAGMENT, ITS CONJUGATE, PHARMACEUTICAL COMPOSITION AND METHOD FOR TREATMENT OF HORMONE-DEPENDENT TUMORS | 2005 |
|
RU2285537C1 |
PEPTIDES EXHIBITING ANTIMICROBIAL ACTIVITY | 2005 |
|
RU2302425C2 |
HEXAPEPTIDE (BIVALFOR) SHOWING ANTITUMOR ACTIVITY | 1993 |
|
RU2064935C1 |
Authors
Dates
2005-01-27—Published
2002-12-27—Filed